A Study of Efavirenz in Combination With Stavudine and Didanosine

NCT00002225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Efavirenz
DRUG: Stavudine
DRUG: Didanosine

Sponsor

Dupont Merck